Design Therapeutics
DSGN
DSGN
83 hedge funds and large institutions have $413M invested in Design Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% less ownership
Funds ownership: 74.2% → 72.2% (-2%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
40% less capital invested
Capital invested by funds: $692M → $413M (-$280M)
Holders
83
Holding in Top 10
2
Calls
$5.82M
Puts
$1.24M
Top Buyers
| 1 | +$21.8M | |
| 2 | +$9.23M | |
| 3 | +$3.85M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$2.35M |
| 5 |
Rafferty Asset Management
New York
|
+$2.18M |
Top Sellers
| 1 | -$19.5M | |
| 2 | -$16.8M | |
| 3 | -$7.64M | |
| 4 |
Goldman Sachs
New York
|
-$7.38M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$4.69M |